Community West Bancshares (NASDAQ:CWBC) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Community West Bancshares is a bank holding company in the United States. It earns revenue through the interest income derived from the provision of lending products. Community West Bancshares has a market cap of $92.170 million; its shares were traded at around $11.25 with a P/E ratio of 19.75 and P/S ratio of 2.77. The dividend yield of Community West Bancshares stocks is 1.42%.
For the last quarter Community West Bancshares reported a revenue of $9.37 million, compared with the revenue of $8.30 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $35.6 million, an increase of 13.6% from last year. For the last five years Community West Bancshares had an average revenue growth rate of 4.5% a year.
The reported diluted earnings per share was 57 cents for the year, a decline of 8.1% from the previous year. Over the last five years Community West Bancshares had an EPS growth rate of 2.2% a year. The Community West Bancshares enjoyed an operating margin of 29.38%, compared with the operating margin of 28.21% a year before. The 10-year historical median operating margin of Community West Bancshares is 13.69%. The profitability rank of the company is 3 (out of 10).
Best Bank Stocks To Invest In 2018: Qualstar Corporation(QBAK)
- [By Jim Robertson]
On Thursday, our Under the Radar Moversnewsletter suggestedpreemptively shorting small cap data storage systems stockQualstar Corporation (NASDAQ: QBAK):
- [By Jim Robertson]
On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap data storage systems stock Qualstar Corporation (NASDAQ: QBAK):
Quelstar is essentially a mirror image of Pixelworks. That is, it’s not just the bearish undertow we want to tap into here. It’s the failure of QBAK to follow-through on today’s effort to break above the 100-day moving average line with today’s early effort. The market dared the bulls to play their hand, and as it turns out, they were bluffing. The sheer scope of the reversal bar in the meantime today confirms the downtrend.
- [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
- [By Lisa Levin]
Qualstar Corporation (NASDAQ: QBAK) was down, falling around 16 percent to $6.99. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 million.
Best Bank Stocks To Invest In 2018: Zions Bancorporation(ZION)
- [By ]
This Utah-based bank is out with its results on April 23. And ahead of this all-important date, top Vining Sparks analyst Marty Mosby has upgraded Zions (ZION) from ‘Buy’ to ‘Strong Buy.’ He writes” “We believe that Zions should be able to generate stronger revenue per share growth than the market currently anticipates, as it should benefit from both rising interest rates and their respective strategic initiatives.”
- [By Nelson Hem]
See what Barron's feels the prospects are for Energy Transfer Partners LP (NYSE: ETP) if it cuts its distribution and dumps its general partner, and salesforce.com, inc. (NYSE: CRM) with its generous potential upside. Also whether regional banks like Zions Bancorp (NASDAQ: ZION) could see a boost from a proposed regulatory change, and the sweetheart deal the Koch brothers got with Meredith Corporation (NYSE: MDP).
- [By Jon C. Ogg]
In the super-regional banks that are not money center banks, Regions Financial Corp. (NYSE: RF) was up 6.3% at $13.22, and Zions Bancorporation (NASDAQ: ZION) was last seen up 3.8% at $38.30. They would both do better with lower regulatory costs and be able to better compete against larger banks when their stress test results had not been as strong.
Best Bank Stocks To Invest In 2018: Dupont Fabros Technology, Inc.(DFT)
- [By Lisa Levin]
DuPont Fabros Technology, Inc. (NYSE: DFT) shares shot up 10 percent to $61.07. Digital Realty Trust, Inc. (NYSE: DLR) announced plans to merge with DuPont Fabros.